Manuscripts
Showing 1589 manuscripts.
Understanding practices of lactation and infant feeding together with women with HIV: the UPLIFT observational study protocol
Citation
Christiana Smith, Emily Anne Barr, Karen Hampanda, Mark Trumbull, Hulin Wu, Jennifer McKinney, Sarah Buisson, Carly Hoffmann, Ciarra Covin, Angela Hutchinson, K. Rivet Amico, Ifeyinwa V. Asiodu, Elizabeth J. McFarland, Margaret Lampe, Preetam A. Cholli, Olga Varechtchouk, Allahna Esber, Athena P. Kourtis, Lisa Abuogi, UPLIFT (IMPAACT 2046) study team. Understanding practices of lactation and infant feeding together with women with HIV: the UPLIFT observational study protocol. Frontiers in Reproductive Health. 2026. 8Year
2026
Journal
Frontiers in Reproductive Health
Study
IMPAACT 2046
Validation of an UHPLC-MS/MS Assay for the Quantification of Isoniazid and Four Major Metabolites in Human Plasma
Citation
David Nerguizian, Brandon Klein, Farah Abdelmawla, Joe Gomez , Peter L Anderson, Lane Bushman, Kristina M Brooks. Validation of an UHPLC-MS/MS Assay for the Quantification of Isoniazid and Four Major Metabolites in Human Plasma. Biomedical Chromatography. 2026. PMID: 42466481Year
2026
Journal
Biomedical Chromatography
Study
P1078
Participant acceptability and clinician satisfaction of cognitive behavioural therapy and medication management algorithm compared with enhanced standard care for treatment of depression among youth with HIV
Citation
Emily A. Barr, Kristin Baltrusaitis, Betsy D. Kennard, Graham J. Emslie, Chelsea Krotje, Kevin Knowles, Sarah Buisson, Lauren Bergam, Jaime Deville, Susan Gillespie, Melissa Shikora, Ellen Townley, David E. Shapiro, Larry K. Brown. Participant acceptability and clinician satisfaction of cognitive behavioural therapy and medication management algorithm compared with enhanced standard care for treatment of depression among youth with HIV. Journal of Child & Adolescent Mental Health. 2025. 36: 108-123. PMID: 39550758Year
2025
Journal
Journal of Child & Adolescent Mental Health
Study
IMPAACT 2002
Lipid and glucose profiles in pregnant women with HIV on tenofovir-based antiretroviral therapy
Citation
Ahizechukwu Eke, Sean Brummel, Muktar H Aliyu, Lynda Stranix-Chibanda, George Uchenna Eleje, Ifeanyi Ezebialu, Violet Korutaro, Deo Wabwire, Allen Matubu, Tapiwa Mbengeranwa, Nahida Chakhtoura, Lameck Chinula, Katie McCarthy, Kevin Knowles, Chelsea Krotje, MacRae F Linton, Kelly Dooley, Paul Sax, Todd Brown, Shahin Lockman, IMPAACT 2010/VESTED Study Team. Lipid and glucose profiles in pregnant women with HIV on tenofovir-based antiretroviral therapy. Clinical Infectious Diseases. 2025. 80: 594-601. PMID: 39219495Year
2025
Journal
Clinical Infectious Diseases
Study
IMPAACT 2010
Bone mineral density changes in breastfeeding women living with HIV on antiretroviral therapy in Eastern and Southern Africa
Citation
Flavia Matovu Kiweewa, Lynda Stranix-Chibanda, Nonhlanhla Yende-Zuma, Sufia Dadabhai, Maxensia Owor, Sherika Hanley, Mandisa Nyati, Lameck Chinula, John M. Pettifor, Sean S. Brummel, Jim Aizire, Taha E. Taha, Todd T. Brown, Mary Glenn Fowler, Maternal Bone Health Study Team. Bone mineral density changes in breastfeeding women living with HIV on antiretroviral therapy in Eastern and Southern Africa. AIDS. 2025. 39: 848-856. PMID: 39918445Year
2025
Journal
AIDS
Study
P1084s
Pharmacokinetics and safety of bictegravir in pregnant and postpartum persons with HIV and their infants
Citation
Kathleen M. Powis, Mauricio Pinilla, Flynn McMorrow, Alice Stek, Kristina M. Brooks, David E. Shapiro, Kevin Knowles, Ahizechukwu C. Eke, Elizabeth Greene, Allison Agwu, Lourdes Topete, Renee Browning, Nahida Chakhtoura, Priyanka Arora, Xiaoying Huang, Brookie M. Best, Mark Mirochnick, Jeremiah D. Momper, IMPAACT 2026 Protocol Team. Pharmacokinetics and safety of bictegravir in pregnant and postpartum persons with HIV and their infants. Journal of Acquired Immune Deficiency Syndromes. 2025. 98: 300-307. PMID: 39813286Year
2025
Journal
Journal of Acquired Immune Deficiency Syndromes
Study
IMPAACT 2026
Bone Mineral Content, Growth, and Renal Health of Infants With Perinatal Exposure to Maternal Dolutegravir Versus Efavirenz and Tenofovir Disoproxil Fumarate Versus Tenofovir Alafenamide: The Randomized IMPAACT 2010 (VESTED) Trial
Citation
Tapiwa Mbengeranwa, Lauren Ziemba, Sean S. Brummel, Ben Johnston, Haseena Cassim, Gerhard Theron, Zukiswa Ngqawana, Deo Wabwire, Katie McCarthy, John Shepherd, Shahin Lockman, Lameck Chinula, Lynda Stranix-Chibanda, IMPAACT 2010/VESTED study team and investigators. Bone Mineral Content, Growth, and Renal Health of Infants With Perinatal Exposure to Maternal Dolutegravir Versus Efavirenz and Tenofovir Disoproxil Fumarate Versus Tenofovir Alafenamide: The Randomized IMPAACT 2010 (VESTED) Trial. Journal of AIDS. 2025. 99: 211-219. PMID: 40001275Year
2025
Journal
Journal of AIDS
Study
IMPAACT 2010
Safety of combined long-acting injectable cabotegravir and long-acting injectable rilpivirine in virologically suppressed adolescents with HIV (IMPAACT 2017/MOCHA): a phase 1/2, multicentre, open-label, non-comparative, dose-finding study
Citation
Carolyn Bolton Moore, Kristin Baltrusaitis, Brookie M. Best, John H. Moye, Ellen Townley, Avy Violari, Barbara Heckman, Sarah Buisson, Rodica M. Van Solingen-Ristea, Edmund V. Capparelli, Mark A. Marzinke, Elizabeth D. Lowenthal, Shawn Ward, Chelsea Krotje, Ryan Milligan, Allison L. Agwu, Jenny Huang, Amy Cheung, Cynthia McCoig, Dwight E. Yin, Gilly Roberts, Herta Crauwels, Veerle Van Eygen, Sara Zabih, Gaerolwe Masheto, Pradthana Ounchanum, Linda Aurpibul, Violet Korutaro, Aditya H. Gaur, IMPAACT 2017 Collaborators. Safety of combined long-acting injectable cabotegravir and long-acting injectable rilpivirine in virologically suppressed adolescents with HIV (IMPAACT 2017/MOCHA): a phase 1/2, multicentre, open-label, non-comparative, dose-finding study. Lancet HIV. 2025. 12: e191-e200. PMID: 40049924Year
2025
Journal
Lancet HIV
Pharmacokinetics and Safety of Levofloxacin for Treatment of Rifampicin-Resistant Tuberculosis During Pregnancy and the Postpartum Period: Results from IMPAACT P1026s.
Citation
Jennifer A. Hughes, Mauricio Pinilla, Kristina M. Brooks, Ahizechukwu C. Eke, Alice Stek, Brookie M. Best, Mark Mirochnick, Renee Browning, Lubbe Wiesner, Kathleen George, Kevin Knowles, Petra De Koker, Nahida Chakhtoura, Anneke C. Hesseling, Eric Decloedt, David E. Shapiro, Marije van Schalkwyk, IMPAACT P1026s Protocol Team. Pharmacokinetics and Safety of Levofloxacin for Treatment of Rifampicin-Resistant Tuberculosis During Pregnancy and the Postpartum Period: Results from IMPAACT P1026s.. Clinical Pharmacology. 2025. 64: 619-630. PMID: 40155501Year
2025
Journal
Clinical Pharmacology
Study
P1026S
The effect of pregnancy on the population pharmacokinetics of levofloxacin in South Africans with rifampicin-resistant tuberculosis
Citation
Sharon Sawe, Lufina Tsirizani, Richard Court, Kamunkhwala Gausi, Asanda Poswa, Tasnim Badat, Lubbe Wiesner, Marian Loveday, Gary Maartens, Francesca Conradie, Paolo Denti. The effect of pregnancy on the population pharmacokinetics of levofloxacin in South Africans with rifampicin-resistant tuberculosis. Antimicrobial Agents and Chemotherapy. 2025. PMID: 40167446Year
2025
Journal
Antimicrobial Agents and Chemotherapy
Study
P1078